Litigation Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)
✉ Email this page to a colleague
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)
Docket | ⤷ Sign Up | Date Filed | 2023-06-29 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Claire Claudia Cecchi |
Jury Demand | None | Referred To | Leda Dunn Wettre |
Patents | 7,284,474; 7,896,264 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC
Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2024-07-24 | 77 | Stipulation and Order | and Affirmative Defenses regarding U.S. Patent Nos. 7,284,474 and 7,896,264. All claims, counterclaims…collectively, "Boehringer") relating to the '474 and '264 patents are dismissed as moot, without prejudice. Signed… 29 June 2023 2:23-cv-03530 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |